A practical algorithm for the management of patients with statin-associated muscle symptoms
Summary: Statin-associated muscle symptoms (SAMS) are the most frequent clinically relevant adverse effects of statins causing discontinuation of statin treatment, and subsequent increase in cardiovascular events. The incidence of SAMS in clinical practice is 5-10%. Clinical manifestations of SAMS a...
Main Author: | Loukianos S. Rallidis |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-03-01
|
Series: | Hellenic Journal of Cardiology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1109966619302842 |
Similar Items
-
Medical Management of Dyslipidemia for Secondary Stroke Prevention: Narrative Review
by: Yoonkyung Chang, et al.
Published: (2023-04-01) -
Improving statin treatment strategies to reduce LDL-cholesterol: factors associated with targets’ attainment in subjects with and without type 2 diabetes
by: Mario Luca Morieri, et al.
Published: (2021-07-01) -
Updated Understanding of the Crosstalk Between Glucose/Insulin and Cholesterol Metabolism
by: Xuan Xiao, et al.
Published: (2022-04-01) -
Targeted Strategy in Lipid-Lowering Therapy
by: Ezgi Dayar, et al.
Published: (2022-05-01) -
Mechanism of action and therapeutic use of bempedoic acid in atherosclerosis and metabolic syndrome
by: Gianni Biolo, et al.
Published: (2022-10-01)